Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Claus Crone Fuglsang

Claus Crone Fuglsang, Niva DK

Patent application numberDescriptionPublished
20090047384LIPOLYTIC ENZYME VARIANTS - The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses.02-19-2009
20100022433Alpha-Amylase Mutants with Altered Properties - The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered stability, in particular at high temperatures and/or at low pH relative, and/or low Ca01-28-2010
20100099161Alpha-Amylase Mutants With Altered Properties - The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered stability, in particular at high temperatures and/or at low pH relative, and/or low Ca04-22-2010
20100190681Alpha-Amylase Mutants with Altered Properties - The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered stability, in particular at high temperatures and/or at low pH relative, and/or low Ca07-29-2010
20100291262Lipolytic Enzyme Variants - The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses.11-18-2010

Patent applications by Claus Crone Fuglsang, Niva DK

Claus Crone Fuglsang, Vekso DK

Patent application numberDescriptionPublished
20080317726Proteases for Pharmaceutical Use - The pharmaceutical use of proteases related to amino acids 1-274 of SEQ ID NO: 2, the serine protease derived from 12-25-2008
20090029004PHYTASE VARIANTS - The present invention relates to phytase variants derived from a parent phytase which is homologous to a 01-29-2009
20100135978Proteases for Pharmaceutical Use - The pharmaceutical use of proteases related to amino acids 1-274 of SEQ ID NO: 2, the serine protease derived from 06-03-2010
20110110910Proteases for Pharmaceutical Use - The pharmaceutical use of proteases related to amino acids 1-274 of SEQ ID NO: 2, the serine protease derived from 05-12-2011

Patent applications by Claus Crone Fuglsang, Vekso DK